Form ARS Allogene Therapeutics, For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research
- Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
- Book Publishing Services in the USA: What Authors Should Know Before Choosing a Publisher
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
